Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14625) 14625
Book Chapter (156) 156
Dissertation (28) 28
Publication (28) 28
Conference Proceeding (20) 20
Newsletter (19) 19
Streaming Video (17) 17
Magazine Article (12) 12
Web Resource (9) 9
Book / eBook (5) 5
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10895) 10895
science & technology (10219) 10219
drug-eluting stents (9913) 9913
life sciences & biomedicine (9790) 9790
cardiovascular system & cardiology (7983) 7983
cardiac & cardiovascular systems (7647) 7647
male (7037) 7037
female (6179) 6179
treatment outcome (5640) 5640
middle aged (5312) 5312
aged (5106) 5106
stents (4089) 4089
stent (3432) 3432
time factors (2937) 2937
drug-eluting stent (2912) 2912
coronary angiography (2757) 2757
percutaneous coronary intervention (2671) 2671
coronary artery disease - therapy (2561) 2561
risk factors (2387) 2387
prosthesis design (2343) 2343
cardiovascular (2222) 2222
follow-up studies (2033) 2033
drug-eluting stents - adverse effects (2032) 2032
sirolimus - administration & dosage (1913) 1913
abridged index medicus (1754) 1754
prospective studies (1636) 1636
biological and medical sciences (1612) 1612
medical sciences (1608) 1608
coronary heart disease (1591) 1591
angioplasty, balloon, coronary - instrumentation (1584) 1584
angioplasty, balloon, coronary - adverse effects (1479) 1479
cardiology (1446) 1446
coronary artery disease (1398) 1398
retrospective studies (1394) 1394
thrombosis (1362) 1362
percutaneous coronary intervention - instrumentation (1350) 1350
percutaneous coronary intervention - adverse effects (1300) 1300
angioplasty (1279) 1279
cardiovascular agents - administration & dosage (1247) 1247
cardiology. vascular system (1225) 1225
sirolimus - analogs & derivatives (1173) 1173
care and treatment (1161) 1161
restenosis (1148) 1148
registries (1144) 1144
risk assessment (1139) 1139
angioplasty, balloon, coronary (1109) 1109
transluminal angioplasty (1091) 1091
coronary artery disease - surgery (1077) 1077
coronary restenosis - prevention & control (1052) 1052
paclitaxel - administration & dosage (1051) 1051
analysis (1031) 1031
aged, 80 and over (1023) 1023
heart attacks (1020) 1020
coronary restenosis - etiology (1008) 1008
heart (993) 993
coronary artery disease - diagnostic imaging (986) 986
percutaneous coronary intervention - methods (983) 983
angioplasty, balloon, coronary - methods (971) 971
coronary artery disease - mortality (953) 953
myocardial infarction - etiology (948) 948
coronary vessels (919) 919
platelet aggregation inhibitors - therapeutic use (910) 910
absorbable implants (905) 905
coronary stenosis - therapy (898) 898
radiotherapy. instrumental treatment. physiotherapy. reeducation. rehabilitation, orthophony, crenotherapy. diet therapy and various other treatments (879) 879
kaplan-meier estimate (866) 866
myocardial infarction (861) 861
peripheral vascular disease (861) 861
cardiovascular disease (840) 840
animals (837) 837
cardiology and cardiovascular medicine (837) 837
general & internal medicine (823) 823
medicine, general & internal (814) 814
metals (807) 807
usage (805) 805
myocardial infarction - therapy (798) 798
adult (795) 795
everolimus (776) 776
surgery (758) 758
mortality (749) 749
stent thrombosis (739) 739
cardiovascular diseases (733) 733
coronary vessels - pathology (731) 731
thrombosis - etiology (725) 725
cardiac patients (721) 721
coronary vessels - diagnostic imaging (712) 712
implants (708) 708
tomography, optical coherence (702) 702
paclitaxel (701) 701
coronary artery bypass (685) 685
coronary thrombosis - etiology (681) 681
randomized controlled trials as topic (671) 671
platelet aggregation inhibitors - administration & dosage (666) 666
ultrasonography, interventional (659) 659
optical coherence tomography (639) 639
patients (635) 635
coronary restenosis - diagnostic imaging (629) 629
polymers (625) 625
ticlopidine - analogs & derivatives (617) 617
incidence (609) 609
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14182) 14182
Japanese (271) 271
Portuguese (195) 195
Spanish (177) 177
Chinese (173) 173
German (146) 146
French (79) 79
Russian (78) 78
Polish (59) 59
Korean (58) 58
Italian (37) 37
Turkish (14) 14
Czech (12) 12
Danish (5) 5
Dutch (5) 5
Persian (4) 4
Bosnian (3) 3
Croatian (3) 3
Hungarian (3) 3
Romanian (2) 2
Swedish (2) 2
Hebrew (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients
by Tada, Tomohisa and Byrne, Robert A and Simunovic, Iva and King, Lamin A and Cassese, Salvatore and Joner, Michael and Fusaro, Massimiliano and Schneider, Simon and Schulz, Stefanie and Ibrahim, Tareq and Ott, Ilka and Massberg, Steffen and Laugwitz, Karl-Ludwig and Kastrati, Adnan
JACC. Cardiovascular interventions, ISSN 1936-8798, 2013, Volume 6, Issue 12, pp. 1267 - 1274
bare-metal stent(s) | stent thrombosis | drug-eluting stent(s) | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Multivariate Analysis | Coronary Thrombosis - diagnosis | Coronary Thrombosis - epidemiology | Humans | Metals | Middle Aged | Male | Prosthesis Design | Incidence | Percutaneous Coronary Intervention - instrumentation | Time Factors | Female | Registries | Odds Ratio | Stents | Drug-Eluting Stents | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Chi-Square Distribution | Germany - epidemiology | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Aged | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Predictors of Coronary Stent Thrombosis. The Dutch Stent Thrombosis Registry
by van Werkum, Jochem W and Heestermans, Antonius A and Zomer, A. Carla and Kelder, Johannes C and Suttorp, Maarten-Jan and Rensing, Benno J and Koolen, Jacques J and Brueren, B.R. Guus and Dambrink, Jan-Henk E and Hautvast, Raymond W and Verheugt, Freek W and ten Berg, Jurriën M
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2009, Volume 53, Issue 16, pp. 1399 - 1409
clopidogrel | predictors | bare-metal stent | drug-eluting stent | stent thrombosis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Risk Assessment | Humans | Middle Aged | Risk Factors | Male | Forecasting | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Coronary Angiography | Coronary Artery Disease - complications | Female | Registries | Aged | Coronary Thrombosis - etiology | Heart attacks | Angina pectoris | Stents | Coronary vessels
Journal Article
Details down arrow
3. Full Text Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation　― 5-Year Outcomes
by Miura, Katsuya and Tada, Takeshi and Kuwayama, Akinune and Shimada, Takenobu and Ohya, Masanobu and Amano, Hidewo and Kubo, Shunsuke and Hyodo, Yusuke and Otsuru, Suguru and Habara, Seiji and Tanaka, Hiroyuki and Fuku, Yasushi and Goto, Tsuyoshi and Kadota, Kazushige
Circulation journal : official journal of the Japanese Circulation Society, ISSN 1346-9843, 2017, Volume 81, Issue 10, pp. 1514 - 1521
Stent fracture | Everolimus-eluting stent | Peri-stent contrast staining | Peristent contrast staining | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Middle Aged | Male | Treatment Outcome | Everolimus - administration & dosage | Drug-Eluting Stents - adverse effects | Myocardial Revascularization | Myocardial Infarction | Prosthesis Failure | Prosthesis Implantation - adverse effects | Staining and Labeling | Female | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial
by Stone, Gregg W and Midei, Mark and Newman, William and Sanz, Mark and Hermiller, James B and Williams, Jerome and Farhat, Naim and Mahaffey, Kenneth W and Cutlip, Donald E and Fitzgerald, Peter J and Sood, Poornima and Su, Xiaolu and Lansky, Alexandra J and SPIRIT III Investigators
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2008, Volume 299, Issue 16, pp. 1903 - 1913
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Drug-Eluting Stents | Myocardial Infarction - epidemiology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Ultrasonography, Interventional | Coronary Restenosis - prevention & control | Logistic Models | Male | Paclitaxel - therapeutic use | Angioplasty, Balloon, Coronary | Coronary Angiography | Sirolimus - administration & dosage | Coronary Restenosis - epidemiology | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Female | Aged | Paclitaxel - administration & dosage | Everolimus | Cardiovascular disease | Medical imaging | Stents | Coronary vessels
Journal Article
Details down arrow
5. Impact of the everolimus-eluting stent on stent thrombosis: A meta-analysis of 13 randomized trials
by Baber, Usman and Mehran, Roxana and Sharma, Samin K and Brar, Somjot and Yu, Jennifer and Suh, Jung-Won and Kim, Hyo-Soo and Park, Seung-Jung and Kastrati, Adnan and De Waha, Antoinette and Krishnan, Prakash and Moreno, Pedro and Sweeny, Joseph and Kim, Michael C and Suleman, Javed and Pyo, Robert and Wiley, Jose and Kovacic, Jason and Kini, Annapoorna S and Dangas, George D
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2011, Volume 58, Issue 15, pp. 1569 - 1577
everolimus-eluting | stent thrombosis | drug-eluting stent | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - epidemiology | Sirolimus - analogs & derivatives | Humans | Middle Aged | Male | Thrombosis - epidemiology | Treatment Outcome | Drug-Eluting Stents - adverse effects | Randomized Controlled Trials as Topic | Sirolimus - administration & dosage | Heart Diseases - mortality | Thrombosis - etiology | Female | Myocardial Revascularization - statistics & numerical data | Aged | Everolimus | Immunosuppressive Agents - administration & dosage | Studies | Clinical trials | Heart attacks | Drug therapy | Stents | Mortality
Journal Article
Details down arrow
6. Full Text A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent–In-Stent Restenosis
by Alfonso, Fernando and Pérez-Vizcayno, Maria Jose and Cárdenas, Alberto and García del Blanco, Bruno and Seidelberger, Bernhard and Iñiguez, Andrés and Gómez-Recio, Manuel and Masotti, Mónica and Velázquez, M. Teresa and Sanchís, Juan and García-Touchard, Arturo and Zueco, Javier and Bethencourt, Armando and Melgares, Rafael and Cequier, Angel and Dominguez, Antonio and Mainar, Vicente and López-Mínguez, José R and Moreu, José and Martí, Vicens and Moreno, Raúl and Jiménez-Quevedo, Pilar and Gonzalo, Nieves and Fernández, Cristina and Macaya, Carlos and RIBS V Study Investigators, under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology and Spanish Soc Cardiology and RIBS V Study Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 14, pp. 1378 - 1386
drug-eluting balloon | everolimus-eluting stent | in-stent restenosis | device thrombosis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Confidence intervals | Heart attacks | Medical imaging | Angioplasty | Surgery | Values | Clinical trials | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
by Alfonso, Fernando and Pérez-Vizcayno, Maria Jose and Cárdenas, Alberto and García Del Blanco, Bruno and Seidelberger, Bernhard and Iñiguez, Andrés and Gómez-Recio, Manuel and Masotti, Mónica and Velázquez, M. Teresa and Sanchís, Juan and García-Touchard, Arturo and Zueco, Javier and Bethencourt, Armando and Melgares, Rafael and Cequier, Angel and Dominguez, Antonio and Mainar, Vicente and López-Mínguez, José R and Moreu, José and Martí, Vicens and Moreno, Raúl and Jiménez-Quevedo, Pilar and Gonzalo, Nieves and Fernández, Cristina and Macaya, Carlos and RIBS V Study Investigators, under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 14, pp. 1378 - 1386
drug-eluting balloon | everolimus-eluting stent | in-stent restenosis | device thrombosis | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Follow-Up Studies | Humans | Metals | Middle Aged | Male | Prosthesis Design | Prosthesis Failure | Angioplasty, Balloon, Coronary - mortality | Coronary Angiography - methods | Coronary Restenosis - mortality | Female | Coronary Stenosis - diagnostic imaging | Severity of Illness Index | Drug-Eluting Stents | Sirolimus - therapeutic use | Coronary Stenosis - therapy | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Survival Rate | Treatment Outcome | Coronary Restenosis - diagnostic imaging | Paclitaxel - therapeutic use | Coronary Restenosis - therapy | Spain | Aged | Coronary Stenosis - mortality
Journal Article
Details down arrow
8. Full Text Stent Thrombosis
by Holmes, David R and Kereiakes, Dean J and Garg, Scot and Serruys, Patrick W and Dehmer, Gregory J and Ellis, Stephen G and Williams, David O and Kimura, Takeshi and Moliterno, David J
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2010, Volume 56, Issue 17, pp. 1357 - 1365
dual antiplatelet therapy | bare-metal stent | percutaneous coronary intervention | drug-eluting stent | stent thrombosis | acute myocardial infarction | drugeluting stent | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Thrombosis - etiology | Humans | Platelet Aggregation Inhibitors - administration & dosage | Risk Factors | Thrombosis - prevention & control | Stents - adverse effects | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Thrombosis - diagnosis | Heart attacks | Stents | Mortality | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Drug-Eluting Stent Thrombosis. Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
by de la Torre-Hernández, José M and Alfonso, Fernando and Hernández, Felipe and Elizaga, Jaime and Sanmartin, Marcelo and Pinar, Eduardo and Lozano, Iñigo and Vazquez, Jose M and Botas, Javier and Perez de Prado, Armando and Hernández, Jose M and Sanchis, Juan and Ruiz Nodar, Juan M and Gomez-Jaume, Alfredo and Larman, Mariano and Diarte, Jose A and Rodríguez-Collado, Javier and Rumoroso, Jose R and Lopez-Minguez, Jose R and Mauri, Josepa and ESTROFA Study Grp and ESTROFA Study Group
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2008, Volume 51, Issue 10, pp. 986 - 990
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Multivariate Analysis | Coronary Thrombosis - epidemiology | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Stroke Volume | Coronary Thrombosis - therapy | Disease-Free Survival | Myocardial Infarction - therapy | Sirolimus - administration & dosage | Coronary Disease - therapy | Female | Myocardial Infarction - physiopathology | Registries | Aged | Coronary Thrombosis - etiology | Paclitaxel - administration & dosage | Heart attacks | Drug therapy | Stents | Mortality
Journal Article
Details down arrow
10. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for acute myocardial infarction) trial
by Hofma, Sjoerd H and Brouwer, Jan and Velders, Matthijs A and Van'T Hof, Arnoud W.J and Smits, Pieter C and Queré, Michel and De Vries, Cornelis Jan and Van Boven, Adrianus J
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2012, Volume 60, Issue 5, pp. 381 - 387
percutaneous coronary intervention | drug-eluting stent | stent thrombosis | acute myocardial infarction | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - mortality | Immunosuppressive Agents | Follow-Up Studies | Humans | Middle Aged | Male | Myocardial Infarction - diagnostic imaging | Cause of Death | Angioplasty, Balloon, Coronary | Coronary Thrombosis - diagnostic imaging | Myocardial Infarction - therapy | Coronary Restenosis - mortality | Coronary Thrombosis - prevention & control | Female | Drug Therapy, Combination | Everolimus | Coronary Thrombosis - mortality | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Kaplan-Meier Estimate | Coronary Restenosis - prevention & control | Survival Rate | Coronary Restenosis - diagnostic imaging | Myocardial Revascularization | Coronary Angiography | Aged | Heart attacks | Drug therapy | Cardiology | Stents | Coronary vessels
Journal Article
Details down arrow
11. "Off-Label" Stent Therapy. 2-Year Comparison of Drug-Eluting Versus Bare-Metal Stents
by Applegate, Robert J and Sacrinty, Matthew T and Kutcher, Michael A and Santos, Renato M and Gandhi, Sanjay K and Baki, Talal T and Little, William C
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 6, pp. 607 - 614
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Restenosis - surgery | Myocardial Infarction - mortality | Angioplasty, Balloon, Coronary - instrumentation | Anticoagulants - administration & dosage | Coronary Thrombosis - epidemiology | Humans | Middle Aged | Heparin - administration & dosage | Male | Secondary Prevention | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Drug-Eluting Stents - adverse effects | Myocardial Infarction - therapy | Female | Paclitaxel - administration & dosage | Immunosuppressive Agents - administration & dosage | Peptide Fragments - administration & dosage | Risk Factors | Proportional Hazards Models | Coronary Restenosis - prevention & control | Treatment Outcome | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Sirolimus - administration & dosage | Hirudins - adverse effects | Coronary Thrombosis - etiology | Peptide Fragments - adverse effects | Blood Vessel Prosthesis Implantation | Heart attacks | Drug therapy | Cardiology | Angina pectoris | Stents | Coronary vessels
Journal Article
Details down arrow
12. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: A randomized, controlled, noninferiority trial
by Natsuaki, Masahiro and Kozuma, Ken and Morimoto, Takeshi and Kadota, Kazushige and Muramatsu, Toshiya and Nakagawa, Yoshihisa and Akasaka, Takashi and Igarashi, Keiichi and Tanabe, Kengo and Morino, Yoshihiro and Ishikawa, Tetsuya and Nishikawa, Hideo and Awata, Masaki and Abe, Mitsuru and Okada, Hisayuki and Takatsu, Yoshiki and Ogata, Nobuhiko and Kimura, Kazuo and Urasawa, Kazushi and Tarutani, Yasuhiro and Shiode, Nobuo and Kimura, Takeshi and NEXT Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2013, Volume 62, Issue 3, pp. 181 - 190
everolimus-eluting stent(s) | percutaneous coronary intervention | biolimus-eluting stent(s) | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Single-Blind Method | Polymers - administration & dosage | Coronary Artery Disease - surgery | Sirolimus - analogs & derivatives | Prospective Studies | Absorbable Implants - standards | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Radiography | Sirolimus - administration & dosage | Coronary Artery Disease - diagnostic imaging | Drug-Eluting Stents - standards | Aged, 80 and over | Female | Aged | Coronary Artery Disease - epidemiology | Everolimus
Journal Article
Details down arrow